Veterinary Antimicrobial Susceptibility Testing Market Size & Growth Forecast 2027–2036, By Segments (Animal, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Veterinary Antimicrobial Susceptibility Testing Market size was over USD 1.26 billion in 2026 and is likely to grow at a 8.59% CAGR between 2027 and 2036, attaining USD 2.87 billion by 2036. The industry revenue for 2027 is estimated at USD 1.35 billion.
Get more details on this report
Request Free Sample ReportVeterinary Antimicrobial Susceptibility Testing Market Intelligence Snapshot
Regional Market Dynamics
- North America held 37.37% of the market in 2026, supported by advanced veterinary infrastructure, established diagnostic capabilities, and growing emphasis on antimicrobial resistance surveillance and evidence-based treatment.
- Asia Pacific is the fastest-growing region, driven by expanding livestock production, improving veterinary laboratory infrastructure, rising food safety concerns, and greater adoption of responsible antimicrobial use.
Segment Momentum
- Production animals represented 63.23% of the market in 2026 and are also the fastest-growing animal segment. Demand is supported by antimicrobial resistance monitoring, targeted livestock treatment, food safety priorities, and responsible antimicrobial use.
- Automated AST instruments held 45.93% of the market in 2026 and are also the fastest-growing product segment. They streamline laboratory workflows, reduce manual intervention, standardize testing, and help laboratories manage increasing sample volumes efficiently.
Market Expansion Drivers
- Growing AMR awareness in veterinary care.
- Standardization of susceptibility protocols.
- Molecular diagnostic adoption.
Leading Market Participants
- Prominent companies in the veterinary antimicrobial susceptibility testing market include IDEXX Laboratories (USA), Thermo Fisher Scientific (USA), BioMérieux (France), Zoetis (USA), Merck Animal Health (USA), BD Diagnostics (USA), Bruker (USA), Randox Laboratories (UK), Neogen (USA), Hardy Diagnostics (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.26 billion
- 2027 Estimated Market Size: USD 1.35 billion
- Projected Market Size: USD 2.87 billion by 2036
- Growth Forecast: 8.59% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Animal (Production Animal) | Product (Automated AST Instruments) | End-use (Veterinary Reference Lab)
- Emerging Opportunity Segment: Animal (Production Animal) | Product (Automated AST Instruments) | End-use (Veterinary Reference Lab)
Market Growth Drivers and Industry Trends
Growing AMR awareness in veterinary care
Growing awareness of antimicrobial resistance in veterinary care is increasing the emphasis on accurate antimicrobial susceptibility testing to guide treatment decisions. Veterinarians and animal health professionals are increasingly recognizing the need to identify effective therapies while reducing unnecessary or inappropriate antimicrobial use. This focus is supporting greater adoption of susceptibility testing across livestock, companion animal, and clinical veterinary settings, particularly where recurring infections and treatment failures create concerns about resistance development. Greater attention to responsible antimicrobial stewardship is also encouraging diagnostic laboratories and veterinary practices to incorporate susceptibility testing more routinely into infection management workflows.
Standardization of susceptibility protocols
The standardization of antimicrobial susceptibility testing protocols is supporting more consistent and reliable interpretation of veterinary diagnostic results. Greater alignment around testing procedures, antimicrobial selection, sample handling, and result interpretation is helping veterinary laboratories improve the comparability of findings across different testing environments. Standardized approaches also strengthen confidence among veterinarians when using susceptibility results to select appropriate treatments and monitor resistance patterns. As diagnostic practices become more structured, the integration of standardized susceptibility testing into routine veterinary workflows is expected to support broader utilization across animal health applications.
Molecular diagnostic adoption
The increasing adoption of molecular diagnostics is creating new opportunities for antimicrobial susceptibility testing by enabling faster identification of infectious agents and resistance-associated characteristics. Molecular approaches can complement conventional culture-based methods by providing additional information that supports more targeted clinical decision-making, particularly when rapid intervention is important. Growing demand for efficient veterinary diagnostics is encouraging laboratories and animal healthcare providers to combine pathogen identification with resistance assessment. Continued advances in molecular technologies are therefore supporting the integration of more sophisticated diagnostic workflows within veterinary infection management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing AMR awareness in veterinary care | 2.5% | Short term (≤ 2 yrs) | Europe; North America | High | Moderate |
| Standardization of susceptibility protocols | 2% | Medium term (2–5 yrs) | Asia Pacific; Europe | Medium | Moderate |
| Molecular diagnostic adoption | 1.4% | Long term (5+ yrs) | North America; Asia Pacific | Medium | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of 37.37% in 2026, backed by advanced veterinary healthcare infrastructure, established diagnostic capabilities, and growing awareness of antimicrobial resistance in animal health. Veterinary laboratories and healthcare providers increasingly use antimicrobial susceptibility testing to guide treatment decisions and improve the appropriate use of antimicrobial therapies. Rising adoption of evidence-based veterinary care is encouraging demand for reliable diagnostic testing across companion animals and livestock. Increased surveillance of antimicrobial resistance, greater emphasis on animal disease management, and continued development of veterinary diagnostic capabilities further strengthen the region's market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region in the veterinary antimicrobial susceptibility testing market, driven by expanding livestock production, increasing demand for animal health services, and growing awareness of antimicrobial resistance. The rising importance of food safety and animal disease prevention is encouraging producers and veterinary professionals to adopt more effective diagnostic approaches. Improvements in veterinary laboratories and healthcare infrastructure are also making susceptibility testing more accessible across developing markets. Increasing adoption of modern animal husbandry practices and greater emphasis on responsible antimicrobial use are creating additional opportunities for market expansion throughout the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Diagnostic StewardshipThe U.S. veterinary antimicrobial susceptibility testing market is shaped by antimicrobial stewardship, diagnostic laboratory utilization, and demand for evidence-based treatment decisions. Veterinary practices and laboratories prioritize rapid, reliable susceptibility results to support targeted antimicrobial selection and address resistance concerns across companion-animal and livestock care.
Germany 🇩🇪
Laboratory PrecisionGermany places emphasis on standardized veterinary diagnostics and responsible antimicrobial use, supporting demand for dependable susceptibility testing across clinical settings. Laboratories and veterinary providers prioritize reproducible testing workflows, regulatory alignment, and diagnostic evidence that can guide more targeted antimicrobial therapies.
Japan 🇯🇵
Clinical DiagnosticsJapan’s veterinary antimicrobial susceptibility testing market centers on dependable diagnostic support for companion animals and livestock. Veterinary laboratories increasingly require accurate susceptibility data to refine antimicrobial selection, strengthen infection management, and align clinical practice with prudent antimicrobial-use principles.
South Korea 🇰🇷
Resistance MonitoringSouth Korea’s market priorities include strengthening antimicrobial resistance surveillance and improving diagnostic support for veterinary treatment decisions. Veterinary laboratories and animal-health providers can benefit from accessible susceptibility testing that enables more targeted therapy and supports responsible antimicrobial use across animal populations.
France 🇫🇷
Stewardship IntegrationFrance emphasizes responsible antimicrobial use within veterinary medicine, creating practical demand for susceptibility testing that connects diagnostics with treatment decisions. Veterinary laboratories and practices prioritize standardized testing and actionable results to support antimicrobial stewardship across companion-animal and production-animal applications.
Italy 🇮🇹
Diagnostic AdoptionItaly’s veterinary antimicrobial susceptibility testing market is supported by the need for evidence-based infection management and prudent antimicrobial prescribing. Veterinary laboratories and clinical practices prioritize accessible diagnostic capabilities that can improve pathogen identification, guide therapy selection, and strengthen antimicrobial stewardship in animal health.
Veterinary Antimicrobial Susceptibility Testing Market Share (%), by Animal, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportAnimal Segment Analysis: Production Animal (Largest & Fastest-Growing Segment)
The production animal segment accounted for the largest share of 63.23% in 2026 in the veterinary antimicrobial susceptibility testing market and is also expected to register the fastest growth. Its leading position is supported by the extensive need to monitor and manage antimicrobial resistance across livestock raised for food production, where disease prevention and effective treatment are closely linked to animal health and productivity. Antimicrobial susceptibility testing helps veterinarians identify appropriate treatments by determining how pathogens respond to different antimicrobial agents, supporting more targeted therapeutic decisions and reducing unnecessary antimicrobial use. Growing attention to food safety, animal disease management, responsible antimicrobial stewardship, and the transmission of resistant pathogens across livestock production systems is strengthening demand for testing services and technologies. As producers and veterinary professionals place greater emphasis on maintaining herd and flock health while limiting inappropriate antimicrobial exposure, demand for antimicrobial susceptibility testing in production animals is expected to continue expanding.
Product Segment Analysis: Automated AST Instruments (Largest & Fastest-Growing Segment)
The automated AST instruments segment represented the largest share of 45.93% in 2026 in the veterinary antimicrobial susceptibility testing market and is also expected to experience the fastest growth. Automated antimicrobial susceptibility testing instruments are increasingly valued for streamlining laboratory workflows, reducing manual intervention, and delivering more consistent testing procedures. These systems can support the processing of clinical samples with greater efficiency while helping veterinary laboratories manage growing testing requirements associated with antimicrobial resistance surveillance. Automation also enables standardized analysis and integration with laboratory information workflows, improving operational efficiency and facilitating timely interpretation of susceptibility results. As veterinary diagnostic laboratories seek faster and more reproducible testing processes, the adoption of automated AST instruments is expected to strengthen, particularly where increasing sample volumes and antimicrobial resistance concerns require scalable diagnostic capabilities.
End-use Segment Analysis: Veterinary Reference Lab (Largest & Fastest-Growing Segment)
The veterinary reference lab segment accounted for the largest share of the veterinary antimicrobial susceptibility testing market in 2026 and is also expected to remain the fastest-growing end-use category. Veterinary reference laboratories play a central role in processing specialized diagnostic samples, conducting antimicrobial susceptibility assessments, and supporting veterinarians with laboratory-based evidence for treatment decisions. Their specialized infrastructure and diagnostic expertise enable them to handle testing requirements that may not be readily available in smaller veterinary facilities, making reference laboratories important contributors to antimicrobial resistance monitoring. Increasing demand for standardized diagnostic testing, greater awareness of responsible antimicrobial use, and the need for reliable laboratory confirmation are supporting the role of reference laboratories in veterinary healthcare. As diagnostic practices become more systematic and resistance surveillance gains importance across animal populations, veterinary reference laboratories are positioned to see continued expansion in antimicrobial susceptibility testing activity.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal | Production Animal, Companion Animal | Production Animal | Production Animal |
| Product | Disks & Plates, Culture Media, Accessories & Consumables, Automated AST Instruments | Automated AST Instruments | Automated AST Instruments |
| End-use | Veterinary Reference Lab, Vet Research Institutes, Others | Veterinary Reference Lab | Veterinary Reference Lab |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
The veterinary antimicrobial susceptibility testing market is shaped by the need to deliver reliable, actionable results across diverse animal-health settings while supporting efficient laboratory operations and responsible antimicrobial use. Phenotypic testing provides evidence of microbial response to specific drugs, whereas genotypic methods can identify selected resistance markers; choosing between them requires consideration of the clinical question and the limitations of each approach. Automated workflows, laboratory information system connectivity, and standardized reporting can improve throughput, but must preserve quality control across different specimen types and testing requirements. Rapid point-of-care systems offer potential advantages where centralized testing causes delays, provided accuracy, usability, and affordability meet practical needs. Ultimately, competitive differentiation depends on validated performance, interpretable results, and integration with veterinary treatment decisions, stewardship practices, and applicable reporting requirements.
Major players in the veterinary antimicrobial susceptibility testing market:
- IDEXX Laboratories (USA)
- Thermo Fisher Scientific (USA)
- BioMérieux (France)
- Zoetis (USA)
- Merck Animal Health (USA)
- BD Diagnostics (USA)
- Bruker (USA)
- Randox Laboratories (UK)
- Neogen (USA)
- Hardy Diagnostics (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories (USA) | |||||||
| Thermo Fisher Scientific (USA) | |||||||
| BioMérieux (France) | |||||||
| Zoetis (USA) | |||||||
| Merck Animal Health (USA) | |||||||
| BD Diagnostics (USA) | |||||||
| Bruker (USA) | |||||||
| Randox Laboratories (UK) | |||||||
| Neogen (USA) | |||||||
| Hardy Diagnostics (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| CarbGeM | July 2025 | CarbGeM launched ZOI VET, an artificial intelligence-powered application automating veterinary antimicrobial susceptibility testing by measuring inhibition zones and providing classifications per standards. The platform enables cloud-based data storage and standardized workflows, streamlining testing processes and improving antimicrobial stewardship within veterinary laboratories. |
| bioMérieux | March 2025 | bioMérieux received FDA 510(k) clearance for VITEK COMPACT PRO, an automated system designed for microorganism identification and antimicrobial susceptibility testing. The device improves laboratory workflows, accelerates routine diagnostic results, and supports resistance management in clinical and industrial settings. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Antimicrobial Susceptibility Testing Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Testing Method | Disk Diffusion, Broth Dilution, Gradient Diffusion, Automated Susceptibility Testing |
| Pathogen Type | Gram-Positive Bacteria, Gram-Negative Bacteria, Mycobacteria, Fungi |
| Sample Type | Blood, Urine, Fecal & Rectal Samples, Respiratory Samples, Tissue & Wound Samples, Milk & Other Veterinary Samples |
Veterinary Antimicrobial Susceptibility Testing Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Antimicrobial Stewardship Adoption Pathways |
|
| Resistance Surveillance Infrastructure |
|
| Diagnostic Access in Emerging Markets |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How much revenue does the veterinary antimicrobial susceptibility testing market generate?
How is the veterinary antimicrobial susceptibility testing industry projected to perform over the next decade?
How is growing AMR awareness changing antimicrobial testing practices in veterinary care?
How are standardized protocols and molecular diagnostics strengthening veterinary susceptibility testing?
Why do production animals account for the largest share of the veterinary antimicrobial susceptibility testing market?
How are automated AST instruments improving veterinary diagnostic operations?
Why does North America lead the veterinary antimicrobial susceptibility testing market?
What is driving veterinary antimicrobial susceptibility testing market growth in Asia Pacific?
Who are the major participants shaping the veterinary antimicrobial susceptibility testing landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook